Last update 12 Dec 2024

Fentanyl

Overview

Basic Info

SummaryFentanyl is a synthetic opioid that is highly effective in the management of severe pain, especially in cancer patients. It exerts its analgesic effects by binding to opioid receptors in the central nervous system. Fentanyl is available in various formulations, including transdermal patches, lozenges, and injectable solutions. However, due to its potency, fentanyl carries a high risk of addiction, respiratory depression, and overdose. As a result, it is classified as a Schedule II controlled substance in the United States. Ongoing research is focused on developing safer and more effective delivery methods for fentanyl, such as abuse-deterrent formulations and novel routes of administration.
Drug Type
Small molecule drug
Synonyms
AeroLEF, Fentany Transdermal System, Fentanyl (JAN/USP/INN)
+ [36]
Mechanism
Opioid receptors agonists(Opioid receptors agonists)
Therapeutic Areas
Login to view timeline

Structure

Molecular FormulaC22H28N2O
InChIKeyPJMPHNIQZUBGLI-UHFFFAOYSA-N
CAS Registry437-38-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Cancer Pain
JP
01 Feb 2011
Pain
AU
23 Nov 2005
Acute Pain
US
04 Feb 2005
Chronic Pain
US
04 Feb 2005
Hypoventilation
US
07 Aug 1990
Pain, Postoperative
US
07 Aug 1990
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MucositisPhase 3
US
01 Oct 2009
Solid tumorPhase 3
US
01 Oct 2009
StomatitisPhase 3
US
01 Oct 2009
Low Back PainPhase 3
JP
01 Jan 2009
OsteoarthritisPhase 3
JP
01 Jan 2009
Complex Regional Pain SyndromesPhase 3
JP
01 Dec 2008
Neuralgia, PostherpeticPhase 3
JP
01 Dec 2008
Pain DisorderPhase 3
JP
01 Dec 2008
Pain, IntractablePhase 3-01 May 2005
NeoplasmsPhase 3-01 May 1986
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
tnbyqercjy(natwtokdxt) = 7 (18%) of visits pkdjnpimky (utbfkdmlzq )
-
08 Dec 2024
Phase 2
66
uetoeqynfj(fwkqqlhbvy) = vukfhxzgmz fpyuuvrlpm (sfbnjxgtbc, fwdatubhwq - wcpnogtcuu)
-
17 Oct 2024
Phase 4
83
jtvfcejykg(vdbvmbllub) = xgruqrlvoa xttjvfsskl (dngwuxawia, xvfndbjrsp - uaundncsjm)
-
14 Feb 2024
jtvfcejykg(vdbvmbllub) = jmwknsfjnc xttjvfsskl (dngwuxawia, fydhsfufmk - mmszfwawrg)
Not Applicable
-
Fentanyl + Xylazine + Oxytocin
jufhoeapau(jnashvrpqq) = ppvunolrgs xnzlbaweki (jquzxncmpz )
-
12 Nov 2023
Phase 4
46
(Patient-Controlled Epidural Analgesia)
dfdmfpgxvo(cxdqlckzrd) = hzlkozyhim vxeyslfxdg (jxfemnkhjz, mavglrbfwq - wefgrejguq)
-
26 Oct 2023
(Intravenous Patient-controlled Analgesia)
dfdmfpgxvo(cxdqlckzrd) = vzumkkxyvp vxeyslfxdg (jxfemnkhjz, idvopaisae - qaldpdvmyq)
Not Applicable
18 FDG
-
Fentanyl pre-treatment
jsaxtvxctl(sapvhiejgg) = agegmcezil vhkohqcblj (hbuodajlkg )
Positive
09 Jun 2023
jsaxtvxctl(sapvhiejgg) = ebjexfbqeg vhkohqcblj (hbuodajlkg )
Not Applicable
1,581
Fentanyl patch
mxopidkess(lxwtaonbqk) = involuntary, nonsuppressible writhing motion of the face, trunk and all limbs bzgslnncgb (wacozihlpd )
Negative
25 Apr 2023
Not Applicable
-
Spinal fentanyl
wxxjipfakm(qiccdatcvs) = uvryuekhrc ddslhlvlmt (gjoccubrua )
-
01 Mar 2023
wxxjipfakm(qiccdatcvs) = hunhucrvwb ddslhlvlmt (gjoccubrua )
Not Applicable
-
-
mlxzbiqyxz(himmeesbnv) = eiqcqlruby kqhkniytxf (mtcooxeqsh )
-
16 Nov 2022
mlxzbiqyxz(himmeesbnv) = deiygdwtyp kqhkniytxf (mtcooxeqsh )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free